Prehabilitation for Colorectal Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Prehabilitation for Colorectal Cancer?
Research shows that prehabilitation, which includes exercise, nutrition, and psychological support before surgery, can improve physical fitness and reduce complications after surgery for colorectal cancer patients. Studies found that patients who underwent prehabilitation had better physical condition and fewer postoperative complications compared to those who did not.12345
Is prehabilitation safe for humans?
How is prehabilitation treatment different for colorectal cancer?
Prehabilitation for colorectal cancer is unique because it focuses on improving a patient's physical condition before surgery through a combination of exercises, nutrition, and psychological support, which can help enhance recovery after surgery. Unlike standard treatments that focus on the surgery itself, prehabilitation aims to optimize the patient's health beforehand, especially benefiting older or frail patients who are at higher risk for complications.12489
What is the purpose of this trial?
Despite multi-modal prehabilitation (nutrition, exercise, and psychosocial interventions), 60% of older elective colorectal cancer surgery patients with poor physical function were unable to reach a minimum preoperative 400m six-minute walking distance (6MWD), a prognostic cut-point. Compared to the patients that attained \>400m 6MWD preoperatively, twice as many of \<400m patients were malnourished. Malnutrition has long been associated with worse functioning (e.g., physical, immune). The investigators hypothesize that for nutritionally deficient patients, the etiology for their poor physical function is malnutrition. Correction of malnutrition alone might thus be sufficient to achieve a 400m 6MWD before surgery and improve patient outcomes.
Research Team
Chelsia Gillis, RD PhD
Principal Investigator
McGill University
Eligibility Criteria
This trial is for older adults (65+) with colorectal cancer who are malnourished and have a low walking distance (less than 400m in six minutes). They must be scheduled for surgery but not have metastatic cancer or conditions like dementia, Parkinson's, or stroke that would make exercise unsafe.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Prehabilitation
Participants receive nutrition prehabilitation alone or with supportive exercise to improve physical function before surgery
Follow-up
Participants are monitored for safety and effectiveness after prehabilitation
Treatment Details
Interventions
- Prehabilitation
Prehabilitation is already approved in European Union, United States, Canada for the following indications:
- Preparation for liver transplantation in patients with cirrhosis
- Preparation for liver transplantation in patients with cirrhosis
- Preparation for liver transplantation in patients with cirrhosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborator